Thu, December 5, 2019
Wed, December 4, 2019
Tue, December 3, 2019
Mon, December 2, 2019
Fri, November 29, 2019
Wed, November 27, 2019

Matthew Luchini Downgraded (BOLD) to Hold and Increased Target to $60 on, Dec 3rd, 2019

Matthew Luchini of BMO Capital, Downgraded "Boundless Bio, Inc." (BOLD) to Hold and Increased Target from $47 to $60 on, Dec 3rd, 2019.

Matthew has made no other calls on BOLD in the last 4 months.



There is 1 other peer that has a rating on BOLD. Out of the 1 peers that are also analyzing BOLD, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $40 on, Tuesday, November 19th, 2019